Platypus Technologies, LLC
5520 Nobel Drive, Suite 100
Madison, WI 53711
Platypus Technologies, LLC a life sciences nanotechnology company has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant for $450,000 from the National Institutes of General Medical Sciences. The funds will be used to improve the performance of assays utilizing the Company’s proprietary liquid crystal based technology to detect molecules that are important to specific biological responses and disease states. Platypus Technologies has received over $12 million in federal funding to develop nanotechnology products for the physical and life sciences.
About Platypus Technologies, LLC:
Platypus Technologies, LLC develops, produces and markets nanotechnologies for the analytic and life sciences. The Company offers a variety of nanostructured surfaces for use in research and is also developing a range of products that derive from a proprietary platform technology using liquid crystals for the rapid detection of molecular interactions. This technology fuses advances in nanoscale science, materials science, and molecular biology to provide advanced tools for use in proteomics, cell studies, environmental monitoring and in vitro diagnostics. The Company has 20 employees and is located in the Fitchburg Technology Campus.
For more information contact: Minnie Gupta, Director of Marketing